Impact of Low Carbohydrate Diet on Self-Report Fatigue and Weakness in Prostate Cancer Patients

No AccessJournal of UrologyJU Forum1 Sep 2021Impact of Low Carbohydrate Diet on Self-Report Fatigue and Weakness in Prostate Cancer Patients Pao-Hwa Lin, Lauren Howard, and Stephen J. Freedland Pao-Hwa LinPao-Hwa Lin http://orcid.org/0000-0001-5982-9241 Department of Medicine, Nephrology Division, Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina More articles by this author , Lauren HowardLauren Howard Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina More articles by this author , and Stephen J. FreedlandStephen J. Freedland *Correspondence: Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8635 W. 3rd St., Suite 1070W, Los Angeles, California 90048 telephone: 310-423-3497; FAX: 310-423-4711; E-mail Address: [email protected] Center for Integrated Research on Cancer and Lifestyle, Samuel Oschin Comprehensive Cancer Institute and Department of Surgery, Division of Urology Cedars-Sinai Medical Center; Section of Urology, Los Angeles, California Department of Surgery, Durham Veterans Affairs Medical Center, Durham, North Carolina More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001780AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail References 1. : Body composition, fatigue and exercise in patients with prostate cancer undergoing androgen-deprivation therapy. BJU Int 2018; 122: 986. Google Scholar 2. : Prevalence of fatigue and impact on quality of life in castration-resistant prostate cancer patients: the VITAL study. BMC Urol 2019; 19: 92. Google Scholar 3. : The effect of nutrition therapy and exercise on cancer-related fatigue and quality of life in men with prostate cancer: a systematic review. Nutrients 2017; 9: 1003. Google Scholar 4. : A randomized controlled trial of a 6-month low-carbohydrate intervention on disease progression in men with recurrent prostate cancer: Carbohydrate and Prostate Study 2 (CAPS2). Clin Cancer Res 2020; 26: 3035. Google Scholar 5. : Consumer reports of "keto flu" associated with the ketogenic diet. Front Nutr 2020; 7: 20. Google Scholar Funding: National Institutes of Health (NCI K24 CA160653) and the Hartford Foundation. IRB approval (IRB No. 00041857) was obtained at each site (Duke University Medical Center, Cedars-Sinai Medical Center, Durham Veterans Affairs Medical Center, and Maryland Chesapeake Urology Research Associates), and each participant signed a consent before any study activity was conducted. Trial registration: NCT01763944. © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue 3September 2021Page: 499-501 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Pao-Hwa Lin Department of Medicine, Nephrology Division, Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina More articles by this author Lauren Howard Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina More articles by this author Stephen J. Freedland Center for Integrated Research on Cancer and Lifestyle, Samuel Oschin Comprehensive Cancer Institute and Department of Surgery, Division of Urology Cedars-Sinai Medical Center; Section of Urology, Los Angeles, California Department of Surgery, Durham Veterans Affairs Medical Center, Durham, North Carolina *Correspondence: Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8635 W. 3rd St., Suite 1070W, Los Angeles, California 90048 telephone: 310-423-3497; FAX: 310-423-4711; E-mail Address: [email protected] More articles by this author Expand All Funding: National Institutes of Health (NCI K24 CA160653) and the Hartford Foundation. IRB approval (IRB No. 00041857) was obtained at each site (Duke University Medical Center, Cedars-Sinai Medical Center, Durham Veterans Affairs Medical Center, and Maryland Chesapeake Urology Research Associates), and each participant signed a consent before any study activity was conducted. Trial registration: NCT01763944. Advertisement PDF downloadLoading ...